Gapping down
In reaction to earnings/guidance:
- NOTV -24.8%
Select biotech/pharma related names showing weakness after ASH presentation or other data release:
- ACET -36.4%, AFMD -15.2%, ONCT -6.5%, IGMS -2.7%, GRPH -1.5%
Other news:
- ABCM -8.4% (provides update on AIM Delisting)
- IDYA -4.2% (submission of IND Application to the U.S. FDA for PARG development candidate IDE161)
- AMGN -3.1% (confirms it will acquire HZNP for $116.50/share in cash)
- RIVN -2.5% (pauses partnership discussions with Mercedes-Benz on electric van production in Europe)
- NOAH -2.4% (recently received a civil judgment from the Bozhou Intermediate People's Court of Anhui Province)
- HP -1.1% (increased the maximum number of shares authorized to be repurchased in calendar year 2023 to five million common shares)
- ACI -0.8% (Issues Statement Regarding the Denial of a Request for Preliminary Injunction by the Attorney General of the State of Washington and Extension of the Temporary Restraining Order on its Special Dividend Payment)
Analyst comments:
- ACN -2% (downgraded to Underweight from Neutral at Piper Sandler)
- BYD -0.8% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities)